|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Humphris JL, Johns AL, Simpson SH, Cowley
MJ, Pajic M, Chang DK, Nagrial AM, Chin VT, Chantrill LA, Pinese M,
et al: Clinical and pathologic features of familial pancreatic
cancer. Cancer. 120:3669–3675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stan SD, Singh SV and Brand RE:
Chemoprevention strategies for pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 7:347–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu P, Feng J, Sun M, Yuan W, Xiao R,
Xiong J, Huang X, Xiong M, Chen W, Yu X, et al: Synergistic effects
of baicalein with gemcitabine or docetaxel on the proliferation,
migration and apoptosis of pancreatic cancer cells. Int J Oncol.
51:1878–1886. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Von Hoff DD, Ervin T, Arena FP, Chiorean
EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et
al: Increased survival in pancreatic cancer with nab-paclitaxel
plus gemcitabine. N Engl J Med. 369:1691–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Circu ML and Aw TY: Reactive oxygen
species, cellular redox systems, and apoptosis. Free Radic Biol
Med. 48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang H, Ge W, Jiang W, Li D and Ju X:
SRPK1siRNA suppresses K562 cell growth and induces apoptosis via
the PARPcaspase3 pathway. Mol Med Rep. 17:2070–2076.
2018.PubMed/NCBI
|
|
9
|
Liu L, Han C, Yu H, Zhu W, Cui H, Zheng L,
Zhang C and Yue L: Chloroquine inhibits cell growth in human A549
lung cancer cells by blocking autophagy and inducing
mitochondrialmediated apoptosis. Oncol Rep. 39:2807–2816.
2018.PubMed/NCBI
|
|
10
|
Zhu W, Liang Q, Yang X, Yu Y, Shen X and
Sun G: Combination of sorafenib and Valproic acid synergistically
induces cell apoptosis and inhibits hepatocellular carcinoma growth
via down-regulating notch3 and pAkt. Am J Cancer Res. 7:2503–2514.
2017.PubMed/NCBI
|
|
11
|
Yang C, Ma X, Wang Z, Zeng X, Hu Z, Ye Z
and Shen G: Curcumin induces apoptosis and protective autophagy in
castration-resistant prostate cancer cells through iron chelation.
Drug Des Dev Ther. 11:431–439. 2017. View Article : Google Scholar
|
|
12
|
Giordano A and Tommonaro G: Curcumin and
cancer. Nutrients. 5:23762019. View Article : Google Scholar
|
|
13
|
Liczbinski P, Michalowicz J and Bukowska
B: Molecular mechanism of curcumin action in signaling pathways:
Review of the latest research. Phytother Res. 6:10022020.
|
|
14
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Simpson CD, Anyiwe K and Schimmer AD:
Anoikis resistance and tumor metastasis. Cancer Lett. 272:177–185.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
San TT, Khaenam P, Prachayasittikul V,
Sripa B, Kunkeaw N and Chan-On W: Curcumin enhances
chemotherapeutic effects and suppresses ANGPTL4 in
anoikis-resistant cholangiocarcinoma cells. Heliyon. 6:e032552020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia W, Deng F, Fu W, Hu J, Chen G, Gao X,
Tan X, Li G, Liu G and Zhu S: Curcumin suppresses wilms' tumor
metastasis by inhibiting RECK methylation. Biomed Pharmacother.
111:1204–1212. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bachmeier BE, Killian PH and Melchart D:
The role of curcumin in prevention and management of metastatic
disease. Int J Mol Sci. 9:17162018. View Article : Google Scholar
|
|
19
|
Coker-Gurkan A, Celik M, Ugur M, Arisan
ED, Obakan- Yerlikaya P, Durdu ZB and Palavan-Unsal N: Curcumin
inhibits autocrine growth hormone-mediated invasion and metastasis
by targeting NF-κB signaling and polyamine metabolism in breast
cancer cells. Amino Acids. 50:1045–1069. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yassine F, Salibi E and Gali-Muhtasib H:
Overview of the formulations and analogs in the taxanes' story.
Curr Med Chem. 23:4540–4558. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mantripragada KC and Safran H: Optimizing
initial chemotherapy for metastatic pancreatic cancer. Future
Oncol. 12:1125–1133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Azimi H, Khakshur AA, Abdollahi M and
Rahimi R: Potential new pharmacological agents derived from
medicinal plants for the treatment of pancreatic cancer. Pancreas.
44:11–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bar-Sela G, Epelbaum R and Schaffer M:
Curcumin as an anti-cancer agent: Review of the gap between basic
and clinical applications. Curr Med Chem. 17:190–197. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Devassy JG, Nwachukwu ID and Jones PJ:
Curcumin and cancer: Barriers to obtaining a health claim. Nutr
Rev. 73:155–165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hosseini M, Hassanian SM, Mohammadzadeh E,
ShahidSales S, Maftouh M, Fayazbakhsh H, Khazaei M and Avan A:
Therapeutic potential of curcumin in treatment of pancreatic
cancer: Current status and future perspectives. J Cell Biochem.
118:1634–1638. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Diaz Osterman CJ, Gonda A, Stiff T,
Sigaran U, Valenzuela MM, Bennit HR, Moyron RB, Khan S and Wall NR:
Curcumin induces pancreatic adenocarcinoma cell death via reduction
of the inhibitors of apoptosis. Pancreas. 45:101–109. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou X, Su J, Feng S, Wang L, Yin X, Yan J
and Wang Z: Antitumor activity of curcumin is involved in
down-regulation of YAP/TAZ expression in pancreatic cancer cells.
Oncotarget. 7:79076–79088. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su J, Zhou X, Yin X, Wang L, Zhao Z, Hou
Y, Zheng N, Xia J and Wang Z: The effects of curcumin on
proliferation, apoptosis, invasion, and NEDD4 expression in
pancreatic cancer. Biochem Pharmacol. 140:28–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Youns M and Fathy GM: Upregulation of
extrinsic apoptotic pathway in curcumin-mediated antiproliferative
effect on human pancreatic carcinogenesis. J Cell Biochem.
114:2654–2665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujioka S, Sclabas GM, Schmidt C,
Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C and Chiao
PJ: Function of nuclear factor kappaB in pancreatic cancer
metastasis. Clin Cancer Res. 9:346–354. 2003.PubMed/NCBI
|
|
31
|
Aggarwal BB: Nuclear factor-kappaB: The
enemy within. Cancer Cell. 6:203–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Yousefi S and Simon HU:
Necroptosis and neutrophil-associated disorders. Cell Death Dis.
9:1112018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Chen X, Gueydan C and Han J:
Plasma membrane changes during programmed cell deaths. Cell Res.
28:9–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoon S, Kovalenko A, Bogdanov K and
Wallach D: MLKL, the protein that mediates necroptosis, also
regulates endosomal trafficking and extracellular vesicle
generation. Immunity. 47:51–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weinlich R, Oberst A, Beere HM and Green
DR: Necroptosis in development, inflammation and disease. Nat Rev
Mol Cell Biol. 18:127–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Q, Qu C, Xie F, Chen L, Liu L, Liang
X, Wu X, Wang P and Meng Z: Curcumin suppresses
epithelial-to-mesenchymal transition and metastasis of pancreatic
cancer cells by inhibiting cancer-associated fibroblasts. Am J
Cancer Res. 7:125–133. 2017.PubMed/NCBI
|
|
37
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bhatia S, Wang P, Toh A and Thompson EW:
New insights into the role of phenotypic plasticity and EMT in
driving cancer progression. Front Mol Biosci. 7:712020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yoshida K, Toden S, Ravindranathan P, Han
H and Goel A: Curcumin sensitizes pancreatic cancer cells to
gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1
expression. Carcinogenesis. 38:1036–1046. 2017. View Article : Google Scholar : PubMed/NCBI
|
